These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26708754)

  • 1. Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice.
    Assi M; Derbré F; Lefeuvre-Orfila L; Rébillard A
    Free Radic Biol Med; 2016 Feb; 91():204-14. PubMed ID: 26708754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
    Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
    J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia.
    Khamoui AV; Park BS; Kim DH; Yeh MC; Oh SL; Elam ML; Jo E; Arjmandi BH; Salazar G; Grant SC; Contreras RJ; Lee WJ; Kim JS
    Metabolism; 2016 May; 65(5):685-698. PubMed ID: 27085776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidants and muscle atrophy in colon cancer: beneficial or deleterious effects?
    Derbré F; Assi M; Lefeuvre-Orfila L; Vincent S; Chevalier M; Gueritat J; Salaun E; Rebillard A
    Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S22. PubMed ID: 26461307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.
    Aulino P; Berardi E; Cardillo VM; Rizzuto E; Perniconi B; Ramina C; Padula F; Spugnini EP; Baldi A; Faiola F; Adamo S; Coletti D
    BMC Cancer; 2010 Jul; 10():363. PubMed ID: 20615237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aliskiren targets multiple systems to alleviate cancer cachexia.
    Wang C; Guo D; Wang Q; You S; Qiao Z; Liu Y; Dai H; Tang H
    Oncol Rep; 2016 Nov; 36(5):3014-3022. PubMed ID: 27667116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia.
    Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R
    Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
    Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice.
    Bonetto A; Penna F; Minero VG; Reffo P; Bonelli G; Baccino FM; Costelli P
    Curr Cancer Drug Targets; 2009 Aug; 9(5):608-16. PubMed ID: 19508174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice.
    Asp ML; Tian M; Wendel AA; Belury MA
    Int J Cancer; 2010 Feb; 126(3):756-63. PubMed ID: 19634137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.
    Judge SM; Wu CL; Beharry AW; Roberts BM; Ferreira LF; Kandarian SC; Judge AR
    BMC Cancer; 2014 Dec; 14():997. PubMed ID: 25539728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade.
    Lautaoja JH; Lalowski M; Nissinen TA; Hentilä J; Shi Y; Ritvos O; Cheng S; Hulmi JJ
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E852-E865. PubMed ID: 30860875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice.
    Peters SJ; van Helvoort A; Kegler D; Argilès JM; Luiking YC; Laviano A; van Bergenhenegouwen J; Deutz NE; Haagsman HP; Gorselink M; van Norren K
    Oncol Rep; 2011 Jul; 26(1):247-54. PubMed ID: 21503587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.
    Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S
    Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MG132-mediated inhibition of the ubiquitin-proteasome pathway ameliorates cancer cachexia.
    Zhang L; Tang H; Kou Y; Li R; Zheng Y; Wang Q; Zhou X; Jin L
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1105-15. PubMed ID: 23535871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myostatin is a novel tumoral factor that induces cancer cachexia.
    Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
    Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Alcohol Consumption Enhances Skeletal Muscle Wasting in Mice Bearing Cachectic Cancers: The Role of TNFα/Myostatin Axis.
    Li Y; Zhang F; Modrak S; Little A; Zhang H
    Alcohol Clin Exp Res; 2020 Jan; 44(1):66-77. PubMed ID: 31657476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound Z526 alleviates chemotherapy-induced cachectic muscle loss by ameliorating oxidative stress-driven protein metabolic imbalance and apoptosis.
    Gu X; Lu S; Fan M; Xu S; Lin G; Zhao Y; Zhao W; Liu X; Dong X; Zhang X
    Eur J Pharmacol; 2024 Jul; 974():176538. PubMed ID: 38552940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paeoniflorin alleviated muscle atrophy in cancer cachexia through inhibiting TLR4/NF-κB signaling and activating AKT/mTOR signaling.
    Zhu Z; Li C; Gu X; Wang X; Zhang G; Fan M; Zhao Y; Liu X; Zhang X
    Toxicol Appl Pharmacol; 2024 Mar; 484():116846. PubMed ID: 38331105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice.
    Chen MC; Hsu WL; Hwang PA; Chen YL; Chou TC
    Oncotarget; 2016 Aug; 7(32):51608-51618. PubMed ID: 27323407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.